CYBX 54.98 Cyberonics Inc $CYBX Hit a 52 week low of 48.19

New Post Public Reply Private Reply Replies (0) Message Board
Emylers
CYBX 54.98 Cyberonics Inc $CYBX Hit a 52 week low of 48.19 Closing the day 10:45 at 54.98 +6.47 +13.34% With a day low of 48.19 and a total volume of 494,947.

CYBX Recent Posts: http://investorshangout.com/Cyberonics-Inc-CYBX-53862/

CYBX Cyberonics Inc Recent Headline News

Cyberonics up after FQ2 report
Seeking Alpha - at Seeking Alpha - 54 mins ago

CYBX: 54.36 (+5.85)

Cyberonics (CYBX) Marked As A Barbarian At The Gate
at The Street - 58 mins ago
Trade-Ideas LLC identified Cyberonics (CYBX) as a "barbarian at the gate" (strong stocks crossing above resistance with today's range greater than 200%) candidate
CYBX: 54.36 (+5.85)

Cyberonics (CYBX) Q2 2015 Results - Earnings Call Webcast
SA Transcripts - at Seeking Alpha - 2 hrs 20 mins ago

CYBX: 54.36 (+5.85)

Cyberonix updates guidance after FQ2 results
Seeking Alpha - at Seeking Alpha - 2 hrs 22 mins ago

CYBX: 54.36 (+5.85)

Cyberonics beats 2Q profit forecasts
Automated Insights - Thu Nov 20, 6:18AM CST
HOUSTON (AP) _ Cyberonics Inc. (CYBX) on Thursday reported earnings of $17.3 million in its fiscal second quarter.
CYBX: 54.36 (+5.85)

Cyberonics beats by $0.05, misses on revenue
Seeking Alpha - at Seeking Alpha - Thu Nov 20, 6:05AM CST

CYBX: 54.36 (+5.85)

Cyberonics Reports Fiscal 2015 Second Quarter Results
PR Newswire - Thu Nov 20, 6:00AM CST
Cyberonics, Inc. (NASDAQ:CYBX) today announced results for the quarter ended October 24, 2014.
CYBX: 54.36 (+5.85)

Notable earnings before Thursday’s open
Seeking Alpha - at Seeking Alpha - Wed Nov 19, 4:30PM CST

GLOG: 18.88 (+0.22), LQDT: 10.34 (-1.16), PDCO: 47.07 (+0.72), BBY: 38.14 (+2.60), SPB: 89.90 (-1.50), DCI: 40.00 (-2.75), WBAI: 23.86 (-0.54), CYBX: 54.36 (+5.85), JKS: 22.72 (-0.81), PERY: 23.91 (-0.05), DLTR: 65.70 (+3.07), BONT: 8.87 (-0.03), PLCE: 52.42 (+1.05), DATE: 5.10 (-0.19), MBLY: 45.37 (-1.38), BKE: 50.78 (+1.32), BRC: 23.26 (-0.24), SMRT: 14.10 (+0.75)

Epilepsy Patients And Advocates Urged To Deck Their Halls With Purple Lights This Holiday Season
PR Newswire - Wed Nov 19, 10:13AM CST
As the holiday season approaches and people begin planning their decorations, Cyberonics, Inc. is urging them to maintain the momentum of Epilepsy Awareness Month in November by incorporating purple lights into their holiday decor.
CYBX: 54.36 (+5.85)

Only one week left to register for the free Houston area Veteran and Transitioning Military Career Event hosted by Cyberonics
PR Newswire - Thu Nov 13, 7:00AM CST
On November 19th 2014, Houston TX based Cyberonics (www.cyberonics.com) will partner with the MedTech and BioTech Veterans Program (www.mvpvets.org) to conduct a re-careering event for transitioning military and veterans in the Houston, Texas area. There are still seats remaining for this free and innovative opportunity for veterans and transitioning military personnel to learn more about employment opportunities at Cyberonics and in the Medical Device Manufacturing industry.
CYBX: 54.36 (+5.85)

Neurostimulation Devices Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Competitive Scenario And Forecasts, 2012 To 2020
M2 - Thu Nov 13, 2:52AM CST
Industry Insights
BSX: 13.03 (-0.06), MDT: 71.47 (-0.29), CYBX: 54.36 (+5.85)

Cyberonics Shares Down 12.7% Since SmarTrend's Sell Call (CYBX)
Comtex SmarTrend(R) - Mon Nov 10, 9:58AM CST
SmarTrend identified a Downtrend for Cyberonics (NASDAQ:CYBX) on August 22nd, 2014 at $57.31. In approximately 3 months, Cyberonics has returned 12.71% as of today's recent price of $50.02.
CYBX: 54.36 (+5.85)

Seats remaining for the Houston area MVP and Cyberonics Veteran and Transitioning Military Re-careering Event
PR Newswire - Mon Nov 10, 7:00AM CST
On November 19th, 2014, Houston, TX based Cyberonics (www.cyberonics.com) will partner with the MedTech and BioTech Veterans Program (www.mvpvets.org) to conduct a re-careering event for transitioning military and veterans in the Houston, Texas area. There are still seats remaining for this free and innovative opportunity for veterans and transitioning military personnel to learn more about employment opportunities at Cyberonics and in the Medical Device Manufacturing industry.
CYBX: 54.36 (+5.85)

Cyberonics To Report Fiscal Year 2015 Second Quarter Results And Host Webcast And Conference Call On November 20, 2014
PR Newswire - Thu Nov 06, 8:00AM CST
Cyberonics, Inc. (NASDAQ:CYBX) today announced that the company will report financial results for the second quarter ended October 24, 2014 on Thursday, November 20, 2014 before regular market trading hours. The company will conduct a conference call to discuss those results on the same day at 8:00 AM Central Time (9:00 AM Eastern Time).
CYBX: 54.36 (+5.85)

10.4% Return Seen to Date on SmarTrend Cyberonics Call (CYBX)
Comtex SmarTrend(R) - Mon Oct 27, 11:10AM CDT
SmarTrend identified a Downtrend for Cyberonics (NASDAQ:CYBX) on August 22nd, 2014 at $57.31. In approximately 2 months, Cyberonics has returned 10.44% as of today's recent price of $51.32.
CYBX: 54.37 (+5.86)

MedTech and BioTech Veterans Program and Cyberonics Announce Veteran and Transitioning Military Re-careering Event
PR Newswire - Tue Oct 14, 7:00AM CDT
On November 19, 2014, Houston, TX-based Cyberonics, Inc. (NASDAQ: CYBX; www.cyberonics.com) will partner with the MedTech and BioTech Veterans Program (www.mvpvets.org) to conduct a re-careering event for transitioning military and veterans in south Texas.
CYBX: 54.37 (+5.86)

Downtrend Call Working As Cyberonics Stock Falls 12.4% (CYBX)
Comtex SmarTrend(R) - Thu Oct 02, 10:05AM CDT
SmarTrend identified a Downtrend for Cyberonics (NASDAQ:CYBX) on August 22nd, 2014 at $57.31. In approximately 1 month, Cyberonics has returned 12.38% as of today's recent price of $50.21.
CYBX: 54.37 (+5.86)

Interesting CYBX Put And Call Options For November 22nd
DividendChannel.com - Tue Sep 30, 10:03AM CDT
Investors in Cyberonics, Inc. saw new options begin trading this week, for the November 22nd expiration.
CYBX: 54.37 (+5.86)

Cyberonics Inc. (CYBX) Stock Research Links

CYBX Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Top 5 Most Recently Viewed Articles

Next PR Unveils Cutting-Edge AI Optimization Solutions

Updated Category News Views 208

Next PR Launches Innovative AI Optimization Services Next PR, an award-winning public relations firm, has recently introduced its AI Optimization Services, aimed at helping brands maintain visibility and authority in today's AI-driven digital landscape. As companies strive to adapt to the ever-changing world of artificial intelligence and search engine results generated...

Continue Reading
Security and Vulnerability Management Market Set for Growth Surge

Updated Category News Views 144

Overview of the Security and Vulnerability Management Market The Security and Vulnerability Management Market is on an impressive trajectory, predicted to expand from USD 17.55 billion to USD 24.07 billion by 2030, reflecting significant growth propelled by rising global vulnerabilities. Market Growth Drivers Multiple factors are contributing to this market's growth....

Continue Reading
Bybit Unveils Groundbreaking MiCAR-Compliant Platform for Europe

Updated Category News Views 275

Introducing Bybit.eu: A New Era for European Crypto Users Bybit, a leader in the cryptocurrency exchange market and the world's second-largest by trading volume, is evolving by launching Bybit.eu. This fully MiCAR-compliant platform is crafted specifically for users across the European Economic Area (EEA). Bybit EU GmbH operates this platform as a licensed Crypto-Asset...

Continue Reading
Breakthrough Updates on NXP900 Clinical Development Journey

Updated Category News Views 128

Nuvectis Pharma Reports Significant NXP900 Findings Nuvectis Pharma, Inc. (NASDAQ: NVCT), known for its pioneering work in oncology, has shared key insights regarding NXP900 at a recent prestigious cancer research meeting. This innovative drug shows considerable promise in treating advanced cancers. Based on a Phase 1a dose-escalation study, NXP900 demonstrated strong...

Continue Reading
Elon Musk's Heartfelt Christmas Eve Adventure in Snowy Cold

Updated Category News Views 323

The Unexpected Christmas Quest of Elon Musk Christmas is a time when many cherish the joy of giving and receiving gifts. However, when you are someone like Elon Musk, a dynamic CEO known for pushing boundaries with Tesla and SpaceX, a forgotten gift can turn into an extraordinary adventure. Imagine waking on Christmas Eve only to realize that you forgot to buy your...

Continue Reading